Amgen to Pay $762 Million to Settle Marketing Investigations

Amgen (NASDAQ: AMGN  ) announced Wednesday that it has finalized an agreement with the U.S. government, 49 states, and the District of Columbia resolving investigations into promotional practices for six drugs: Aranesp, Epogen, Neuopogen, Neulasta, Enbrel, and Sensipar.

The company pleaded guilty to a single misdemeanor count of misbranding Aranesp by promoting its use in a different way than was described on the label approved by the Food and Drug Administration. Doctors are free to use FDA-approved drugs in any way they see fit, but drug companies aren't allowed to promote the so-called off-label use.

Amgen will pay a criminal fine of $150 million as part of the plea agreement. The company also resolved civil liabilities for which it will pay the state and federal governments $612 million to cover allegedly fraudulent Medicare and Medicaid claims.

"Amgen acknowledges that mistakes were made, and we did not live up to our standards," Cynthia M. Patton, senior vice president and chief compliance officer at Amgen, is quoted as saying in the company press release.

Amgen took a charge in the third quarter of 2011 that will cover the $762 million payments, so the settlement won't have a negative effect on future earnings announcements.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2162505, ~/Articles/ArticleHandler.aspx, 11/27/2014 10:20:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement